Advagene Biopharma Co., Ltd. (TPEX:6709)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.95
-0.90 (-2.92%)
Mar 10, 2026, 12:39 PM CST
25.05%
Market Cap 1.83B
Revenue (ttm) n/a
Net Income (ttm) -71.10M
Shares Out 59.38M
EPS (ttm) -1.23
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 20,704
Average Volume 133,018
Open 30.05
Previous Close 30.85
Day's Range 29.95 - 30.30
52-Week Range 15.75 - 41.00
Beta 0.77
RSI 46.22
Earnings Date Mar 20, 2026

About Advagene Biopharma

Advagene Biopharma Co., Ltd. engages in the research and development of vaccine technology and related products in Taiwan. It engages in the development of nasal spray influenza vaccine; respiratory allergy treatment vaccine, including rhinitis and asthma; COVID-19 immunotherapy; and other vaccines. The company was founded in 2006 and is based in Taipei, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 12
Stock Exchange Taipei Exchange
Ticker Symbol 6709
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.